BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ladas EJ, Kelly KM. Milk thistle: is there a role for its use as an adjunct therapy in patients with cancer? J Altern Complement Med. 2003;9:411-416. [PMID: 12816629 DOI: 10.1089/107555303765551633] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Marceddu R, Dinolfo L, Carrubba A, Sarno M, Di Miceli G. Milk Thistle (Silybum Marianum L.) as a Novel Multipurpose Crop for Agriculture in Marginal Environments: A Review. Agronomy 2022;12:729. [DOI: 10.3390/agronomy12030729] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Wiernikowski JT, Bernhardt MB. Review of nutritional status, body composition, and effects of antineoplastic drug disposition. Pediatr Blood Cancer 2020;67. [DOI: 10.1002/pbc.28207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Hosseinabadi T, Lorigooini Z, Tabarzad M, Salehi B, Rodrigues CF, Martins N, Sharifi‐rad J. Silymarin antiproliferative and apoptotic effects: Insights into its clinical impact in various types of cancer. Phytotherapy Research 2019;33:2849-61. [DOI: 10.1002/ptr.6470] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
4 Neelofar K, Arif Z, Ahmad J, Alam K. Inhibitory effect of silibinin on Amadori-albumin in diabetes mellitus: A multi-spectroscopic and biochemical approach. Spectrochim Acta A Mol Biomol Spectrosc 2019;209:217-22. [PMID: 30399482 DOI: 10.1016/j.saa.2018.10.044] [Reference Citation Analysis]
5 Martinelli T, Whittaker A, Benedettelli S, Carboni A, Andrzejewska J. The study of flavonolignan association patterns in fruits of diverging Silybum marianum (L.) Gaertn. chemotypes provides new insights into the silymarin biosynthetic pathway. Phytochemistry 2017;144:9-18. [PMID: 28863306 DOI: 10.1016/j.phytochem.2017.08.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
6 Yang Z, Liao X, Lu Y, Xu Q, Tang B, Chen X, Yu Y. Add-On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med 2017;2017:3428253. [PMID: 28680448 DOI: 10.1155/2017/3428253] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
7 Naseer O, Khan JA, Khan MS, Omer MO, Chishti GA, Sohail ML, Saleem MU. Comparative Efficacy of Silymarin and Choline Chloride (Liver Tonics) in Preventing the Effects of Aflatoxin B1 in Bovine Calves. Pol J Vet Sci 2016;19:545-51. [PMID: 27760040 DOI: 10.1515/pjvs-2016-0068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Deep G, Agarwal R. Chemopreventive Efficacy of Silymarin in Skin and Prostate Cancer. Integr Cancer Ther 2007;6:130-45. [DOI: 10.1177/1534735407301441] [Cited by in Crossref: 80] [Cited by in F6Publishing: 65] [Article Influence: 13.3] [Reference Citation Analysis]
9 Beydogan AB, Bolkent S. The effects of silibin administration for different time periods on mouse liver with Ehrlich ascites carcinoma. Pharmacol Rep 2016;68:543-9. [PMID: 26891241 DOI: 10.1016/j.pharep.2015.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
10 Andrzejewska J, Martinelli T, Sadowska K. Silybum marianum : non-medical exploitation of the species: Silybum marianum : non-medical exploitation of the species. Ann Appl Biol 2015;167:285-97. [DOI: 10.1111/aab.12232] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
11 Martinelli T, Andrzejewska J, Salis M, Sulas L. Phenological growth stages of Silybum marianum according to the extended BBCH scale: BBCH scale for the growth stages of S. marianum. Ann Appl Biol 2015;166:53-66. [DOI: 10.1111/aab.12163] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
12 Lim R, Morwood CJ, Barker G, Lappas M. Effect of silibinin in reducing inflammatory pathways in in vitro and in vivo models of infection-induced preterm birth. PLoS One 2014;9:e92505. [PMID: 24647589 DOI: 10.1371/journal.pone.0092505] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
13 Zhu HJ, Brinda BJ, Chavin KD, Bernstein HJ, Patrick KS, Markowitz JS. An assessment of pharmacokinetics and antioxidant activity of free silymarin flavonolignans in healthy volunteers: a dose escalation study. Drug Metab Dispos 2013;41:1679-85. [PMID: 23835761 DOI: 10.1124/dmd.113.052423] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
14 Grace S. CAM practitioners in the Australian health workforce: an underutilized resource. BMC Complement Altern Med 2012;12:205. [PMID: 23116374 DOI: 10.1186/1472-6882-12-205] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
15 Veverka M, Šimon P, Gallovič J, Jorík V, Veverková E, Dubaj T. Imatinib mesylate cocrystals: synthesis, screening, and preliminary characterization. Monatsh Chem 2012;143:1405-15. [DOI: 10.1007/s00706-012-0788-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
16 Velmurugan B, Gangar SC, Kaur M, Tyagi A, Deep G, Agarwal R. Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules. Pharm Res 2010;27:2085-97. [PMID: 20628792 DOI: 10.1007/s11095-010-0207-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
17 Kaur M, Velmurugan B, Tyagi A, Deep G, Katiyar S, Agarwal C, Agarwal R. Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft. Mol Cancer Ther 2009;8:2366-74. [PMID: 19638451 DOI: 10.1158/1535-7163.MCT-09-0304] [Cited by in Crossref: 62] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
18 Deep G, Raina K, Singh RP, Oberlies NH, Kroll DJ, Agarwal R. Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: comparison with silymarin and silibinin. Int J Cancer 2008;123:2750-8. [PMID: 18798272 DOI: 10.1002/ijc.23879] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
19 Deep G, Oberlies NH, Kroll DJ, Agarwal R. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells. Int J Cancer 2008;123:41-50. [PMID: 18435416 DOI: 10.1002/ijc.23485] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
20 Maiti TK, Ghosh KS, Samanta A, Dasgupta S. The interaction of silibinin with human serum albumin: A spectroscopic investigation. Journal of Photochemistry and Photobiology A: Chemistry 2008;194:297-307. [DOI: 10.1016/j.jphotochem.2007.08.028] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 3.4] [Reference Citation Analysis]
21 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
22 Wen Z, Dumas TE, Schrieber SJ, Hawke RL, Fried MW, Smith PC. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. Drug Metab Dispos. 2008;36:65-72. [PMID: 17913795 DOI: 10.1124/dmd.107.017566] [Cited by in Crossref: 109] [Cited by in F6Publishing: 107] [Article Influence: 7.3] [Reference Citation Analysis]
23 Post-White J, Ladas EJ, Kelly KM. Advances in the use of milk thistle (Silybum marianum). Integr Cancer Ther 2007;6:104-9. [PMID: 17548789 DOI: 10.1177/1534735407301632] [Cited by in Crossref: 97] [Cited by in F6Publishing: 73] [Article Influence: 6.5] [Reference Citation Analysis]
24 Tamayo C, Diamond S. Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.). Integr Cancer Ther. 2007;6:146-157. [PMID: 17548793 DOI: 10.1177/1534735407301942] [Cited by in Crossref: 84] [Cited by in F6Publishing: 65] [Article Influence: 5.6] [Reference Citation Analysis]
25 Deep G, Oberlies NH, Kroll DJ, Agarwal R. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells. Carcinogenesis. 2007;28:1533-1542. [PMID: 17389612 DOI: 10.1093/carcin/bgm069] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
26 Hlubocky FJ, Ratain MJ, Wen M, Daugherty CK. Complementary and Alternative Medicine Among Advanced Cancer Patients Enrolled on Phase I Trials: A Study of Prognosis, Quality of Life, and Preferences for Decision Making. JCO 2007;25:548-54. [DOI: 10.1200/jco.2005.03.9800] [Cited by in Crossref: 61] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
27 Hawks R. Complementary and alternative medicine research initiatives in the Children's Oncology Group and the role of the pediatric oncology nurse. J Pediatr Oncol Nurs 2006;23:261-4. [PMID: 16902080 DOI: 10.1177/1043454206291358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
28 Křen V, Walterová D. Silybin and silymarin - new effects and applications. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005;149:29-41. [DOI: 10.5507/bp.2005.002] [Cited by in Crossref: 236] [Cited by in F6Publishing: 146] [Article Influence: 13.9] [Reference Citation Analysis]
29 Post-white J, Hawks RG. Complementary and Alternative Medicine in Pediatric Oncology. Seminars in Oncology Nursing 2005;21:107-14. [DOI: 10.1016/j.soncn.2004.12.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]